テキサスにおける強皮症の臨床試験
テキサス内の拠点で、強皮症に関する12件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Tekton Research, Inc - West Gate Boulevard, Austin
- Arthritis & Rheumatology Institute - Frisco, Frisco
- The University of Texas Health Science Center at Houston, Houston
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07497087Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Denison
- GSK Investigational Site, El Paso
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT05878717Platform Clinical Study for Conquering Scleroderma
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/18更新 · NCT06195072A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Dallas
- Nkarta Investigational Site, Houston
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/08/07更新 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Arlington, Arlington
- Artiva Investigational Site Bellaire, Bellaire
- Artiva Investigational Site Irving, Irving
- 他4件
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/31更新 · NCT06991114A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
- The University of Texas Health Science Center at Houston, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/08更新 · NCT06827977Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
- UT Southwestern Medical Center - Department of Dermatology, Dallas
被験者募集中観察研究健康なボランティア歓迎
90歳以下 · 全性別 · 2026/05/12更新 · NCT01808937Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/15更新 · NCT06434363A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
- Galderma Investigational Site#7096, Arlington
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/31更新 · NCT07047690Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
- The University of Texas Health Science Center at Houston, Houston
被験者募集中
18歳以上 · 全性別 · 2025/06/26更新 · NCT05989763Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Dallas
- aTyr Investigative Site, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2025/05/07更新 · NCT05892614ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。